NCT04829149
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Hanmi Pharmaceutical Company Limited Seoul, South Korea
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
948 public trials
78 recruiting studies
Dyslipidemias trial results
NCT03527290
- Conditions
- Blood Pressure, Body Weight, Body Weight Changes, +15 more
- Locations
-
- Institute for Clinical and Translational Science Irvine, California, United States
Completed
Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
NCT04807959
- Conditions
- Body Weight, Cardiovascular Diseases, Central Obesity, +22 more
- Locations
-
Not specified
NCT01262638
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Chandler, Arizona, United States
- Greenbrae, California, United States
- Santa Rosa, California, United States
- Jacksonville, Florida, United States
NCT04802525
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Marwa Eid Cairo, Egypt
NCT00540293
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Daegu, Korea, South Korea
- Pfizer Investigational Site Seoul, Korea, South Korea
- Pfizer Investigational Site Busan, South Korea
- Pfizer Investigational Site Busan, South Korea
NCT02726100
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +8 more
- Locations
-
- Hebei Medical University Shijiazhuang, Hebei, China
- Center of Disease Control and Prevention, Luquan Shijiazhuang, Hebei, China
Completed
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
NCT00673660
- Conditions
- Behavior, Dyslipidemia, Dyslipidemias, +7 more
- Locations
-
- Pfizer Investigational Site Mecidiyeköy, Istanbul, Turkey (Türkiye)
- Pfizer Investigational Site Bolu, Turkey (Türkiye)
- Pfizer Investigational Site Haseki/Istanbul, Turkey (Türkiye)
- Pfizer Investigational Site Istanbul, Turkey (Türkiye)
NCT01304641
- Conditions
- Cardiovascular, Dyslipidemia, Dyslipidemias, +3 more
- Locations
-
Not specified
NCT00644709
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Antwerp, Belgium
- Pfizer Investigational Site Brasschaat, Belgium
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Genk, Belgium